Due to the considerable increase in public expenditure with health issues, mainly regarding drugs, several countries, including Australia and England, have already implemented, or are in the process of discussing the adoption of measures to ensure the quality of health care provided to the population. One of the less harmful strategies, rarely used in Brazil, is the adoption of economic techniques applied to health, more specifically, pharmacoeconomic analysis. This paper aims to contribute to the dissemination of concepts and techniques of economic analysis with a view to incorporate these into policy decisions of expenditure rationalization and the search for clinical efficiency. It includes a literature review covering the types of costs...
AbstractBy today, in our business environment, mostly based on innovation, the potential opportuniti...
Relatório de Estágio do Mestrado Integrado em Ciências Farmacêuticas apresentado à Faculdade de Farm...
Pharmacoeconomics is the description and analysis of the costs of drug therapy to healthcare systems...
Due to the considerable increase in public expenditure with health issues, mainly regarding drugs, s...
O medicamento do ponto de vista da economia (ciência da escassez) é considerado um bem econômico, po...
Due to the significant boost in community expenditure with health topics, mainly regarding drugs, nu...
A farmacoeconomia, uma disciplina nova, surgida no cenário internacional na década de 1980, tem cres...
Este artigo revisa alguns conceitos básicos em atenção farmacêutica e em farmacoeconomia, comenta, s...
Este artículo expone como la farmacoeconomía contribuye a incrementar los niveles de eficiencia en l...
Health expenditures and medication usage have increased dramatically in last years, situation that a...
Due to the significant boost in community expenditure with health topics, mainly regarding drugs, nu...
The new global context, the dramatic rise in the cost of many health technologies, and the mounting ...
A atenção farmacêutica (ATENFAR) é uma nova prática clínica, inerente ao profissional farmacêutico, ...
El presente trabajo aborda los diferentes métodos de evaluación económica aplicados al grupo de los...
In the last years, the growing interest of healthcare professionals, policy-makers, and other stakeh...
AbstractBy today, in our business environment, mostly based on innovation, the potential opportuniti...
Relatório de Estágio do Mestrado Integrado em Ciências Farmacêuticas apresentado à Faculdade de Farm...
Pharmacoeconomics is the description and analysis of the costs of drug therapy to healthcare systems...
Due to the considerable increase in public expenditure with health issues, mainly regarding drugs, s...
O medicamento do ponto de vista da economia (ciência da escassez) é considerado um bem econômico, po...
Due to the significant boost in community expenditure with health topics, mainly regarding drugs, nu...
A farmacoeconomia, uma disciplina nova, surgida no cenário internacional na década de 1980, tem cres...
Este artigo revisa alguns conceitos básicos em atenção farmacêutica e em farmacoeconomia, comenta, s...
Este artículo expone como la farmacoeconomía contribuye a incrementar los niveles de eficiencia en l...
Health expenditures and medication usage have increased dramatically in last years, situation that a...
Due to the significant boost in community expenditure with health topics, mainly regarding drugs, nu...
The new global context, the dramatic rise in the cost of many health technologies, and the mounting ...
A atenção farmacêutica (ATENFAR) é uma nova prática clínica, inerente ao profissional farmacêutico, ...
El presente trabajo aborda los diferentes métodos de evaluación económica aplicados al grupo de los...
In the last years, the growing interest of healthcare professionals, policy-makers, and other stakeh...
AbstractBy today, in our business environment, mostly based on innovation, the potential opportuniti...
Relatório de Estágio do Mestrado Integrado em Ciências Farmacêuticas apresentado à Faculdade de Farm...
Pharmacoeconomics is the description and analysis of the costs of drug therapy to healthcare systems...